MarketInOut Stock Screener Log In | Sign Up
 

Apimeds Pharmaceuticals US Inc

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 05/05/2026 16:00
Apimeds Pharmaceuticals US Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNYSE
Market Capitalization2.36 mln
Float5.54 mln
Earnings Date05/29/2026

Piotroski F-Score

2 / 9
Weak

Relative Strength

100 / 100
Top performer

Debt / Equity

0.06
Debt-free

ROE

-188
Deeply negative

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Business Description

Apimeds Pharmaceuticals US Inc. is a United Arab Emirates-based company focused on building and managing bitcoin holdings as a core part of its financial strategy. It operates under the ownership of Inscobee Inc.

Key Fundamentals

EPS-0.41
ROE-188
ROIC-510
ROA-128
EBITDA, mln-5.05
EV / EBITDA-3.40
EV / EBIT-3.39

Financial Strength

Piotroski F-Score 2 / 9
Short Ratio1.15
Short % of Float1.68

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 57.07% 100 / 100   
1 Month 131% 100 / 100   
2 Months 70.45% 99 / 100   
6 Months 74.42% 97 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us